These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19346576)

  • 61. Aping Jane Goodall: insights into human lymphatic filariasis.
    Ravindran B
    Trends Parasitol; 2003 Mar; 19(3):105-9. PubMed ID: 12643989
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphatic filariasis: diagnosis and pathogenesis. WHO expert committee on filariasis.
    Bull World Health Organ; 1993; 71(2):135-41. PubMed ID: 8490976
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Doubts over India's deadline to defeat lymphatic filariasis.
    Cousins S
    Lancet; 2016 May; 387(10033):2077-2078. PubMed ID: 27301812
    [No Abstract]   [Full Text] [Related]  

  • 64. The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India.
    Babu BV; Nayak AN; Dhal K; Acharya AS; Jangid PK; Mallick G
    Acta Trop; 2002 Apr; 82(1):31-8. PubMed ID: 11904101
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The plight of chronic filarial lymphoedema patients in choice of health care and health care providers in Pondicherry, India.
    Abidha ; Das LK; Yuvraj J; Vijayalaxmi G; Pani SP
    J Commun Dis; 2008 Jun; 40(2):101-9. PubMed ID: 19301694
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elimination of lymphatic filariasis in India--a successful endeavour.
    Srivastava PK; Dhillon GP
    J Indian Med Assoc; 2008 Oct; 106(10):673-4, 676-7. PubMed ID: 19552103
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Locomotor disability in bancroftian filarial lymphoedema patients.
    Das LK; Pani SP; Vinod SK
    J Commun Dis; 2008 Mar; 40(1):13-9. PubMed ID: 19127664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A rare case of ovarian and pelvic filariasis.
    Goel P; Tandon R; Saha PK; Prabhakar S; Goel B; Kaur R; Kaur N; Singhal N
    Trop Doct; 2013 Jul; 43(3):108-9. PubMed ID: 23820743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Editorial: Lymphatic filariasis endemicity--an indicator of poverty?
    Durrheim DN; Wynd S; Liese B; Gyapong JO
    Trop Med Int Health; 2004 Aug; 9(8):843-5. PubMed ID: 15303987
    [No Abstract]   [Full Text] [Related]  

  • 70. The Concept of Chronic Edema-A Neglected Public Health Issue and an International Response: The LIMPRINT Study.
    Moffatt C; Keeley V; Quere I
    Lymphat Res Biol; 2019 Apr; 17(2):121-126. PubMed ID: 30995179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Eliminating lymphatic filariasis: a view from the field.
    Streit T; Lafontant JG
    Ann N Y Acad Sci; 2008; 1136():53-63. PubMed ID: 18579875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lymphatic filariasis and the ISL consensus document.
    Jamal S
    Lymphology; 2005 Dec; 38(4):193-6. PubMed ID: 16515227
    [No Abstract]   [Full Text] [Related]  

  • 73. Leprosy and lymphatic filariasis comorbidity: the case for an integrated functional limitation grading system.
    Rawson TM; Rao PV
    Lepr Rev; 2014 Mar; 85(1):63-7. PubMed ID: 24974445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
    Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
    J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Impact of the COVID-19 Pandemic on People With Lymphedema in an Endemic Area for Lymphatic Filariasis in Brazil.
    de Aquino LT; Aguiar-Santos AM; Rocha A; Coutinho AVA; do Nascimento MSB; Moretti EC; da Silva FL; Lima FM; Bonfim C; Medeiros Z
    Int J Public Health; 2023; 68():1605317. PubMed ID: 36712817
    [No Abstract]   [Full Text] [Related]  

  • 77. India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis.
    Rahi M; Chaturvedi R; Das P; Sharma A
    PLoS Pathog; 2021 May; 17(5):e1009492. PubMed ID: 34015028
    [No Abstract]   [Full Text] [Related]  

  • 78. Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti.
    Hochberg N; Michel MC; Lammie PJ; Mathieu E; Direny AN; De Rochars MB; Addiss DG
    Am J Trop Med Hyg; 2006 Nov; 75(5):928-32. PubMed ID: 17123989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Global significance of the elimination of lymphatic filariasis in China].
    Sun DJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):329-31. PubMed ID: 16562463
    [No Abstract]   [Full Text] [Related]  

  • 80. Lymphatic filariasis.
    Epidemiol Bull; 2004 Dec; 25(4):14-5. PubMed ID: 16127823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.